½ÃŬ·Î½ºÆ÷¸° »ç¿ë ÈÄ ¹ß»ýÇÑ ´ë³úÁ¤¸ÆÇ÷ÀüÁõ
Cerebral Venous Thrombosis Occurred After Cyclosporine Administration
µµÁÖ¿µ, °¼®À±, ±è°æ¿ì, ¿ÀÇÐÁÖ, °¹Ì¸®, ±Ç¼®¹ü, Ȳ¼ºÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
µµÁÖ¿µ ( Do Ju-Young )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
°¼®À± ( Kang Suk-Yun )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±è°æ¿ì ( Kim Kyoung-Woo )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¿ÀÇÐÁÖ ( Oh Hak-Ju )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
°¹Ì¸® ( Kang Mi-Ri )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±Ç¼®¹ü ( Kwon Seok-Beom )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
Ȳ¼ºÈñ ( Hwang Sung-Hee )
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
KMID : 0359720130310020111
Abstract
Cerebral venous thrombosis (CVT) is quite rare and underlying risk factors are diverse. We describe that 60-year-old man developed CVT after use of cyclosporine. He had suffered from leukocytoclastic vasculitis and urticarial vasculitis. Initial MR venogram revealed thrombosis in superior sagittal sinus, right transverse sinus and sigmoid sinus with multiple cortical and deep collateral veins. Anticoagulation was started and maintained for one year, then follow up MR venogram was normal. We suggest that cyclosporine might increase a risk of CVT.
Å°¿öµå
Cyclosporine; Cerebral venous thrombosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸